EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Arkhypkina T. L.

    FOLIC ACID AND ITS ROLE IN THE REPRODUCTIVE HEALTH OF WOMEN WITH POLYCYSTIC OVARY SYNDROME


    About the author: Arkhypkina T. L.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The article deals with the biological role of folic acid and its derivatives in the reproductive function of women. Is accented the attention to the impact of folic acid deficiency in the formation of hyperhomocysteinemia and endothelial dysfunction in patients with polycystic ovary syndrome, and are presented the results of their own observations. Found, that women with PCOS have a folic acid deficiency various degree of expressiveness and increased levels of endothelin-1. A negative correlation between folate and homocysteine concentration in plasma was found. The need to determine the level of folic acid for the timely conduct of events aimed at preventing the development of endothelial dysfunction was indicated.
    Tags polycystic ovary syndrome, folic acid, homocysteine, endothelin-1
    Bibliography
    • Grodnitskaya E. E. Rol narusheniy v obmene folatov i gomotsisteina v razvitii oslozhneniy beremennosti / E. E. Grodnitskaya // Rossiyskiy vestnik akushera ginekologa. – 2010. –No. 4. – S.20 – 24.
    • Dobrohotova Yu. E. Znachenie folievoy kislotyi v akusherstve i perinatologii / Yu. E. Dobrohotova, E. M. Dzhobava, L. H. Heydar [i dr.] // Problemyi reproduktsii. – 2006. – T. 12, No. 1. – S. 98 – 101.
    • Zhukova V. B. Gipergomotsisteyinemiya: stan problemi / V. B. Zhukova, Yu. V. Protas, K. Yu. Gnidenko [ta In.] // Suchasna gastroenterologiya. – 2006. – No. 1. – S. 87 – 92.
    • Kurtser M. A. Folievaya kislota v realizatsii reproduktivnoy funktsii: metod. Rekomendatsii / Departament zdravoohraneniya Moskvyi // M. A. Kurtser, E. E. Grodnitskaya // – M., -2011. – 23 s.
    • Kerkeshko G. O. Optimizatsiya terapii folatami pri oslozhneniyah beremennosti / G. O. Kerkeshko, A. V. Arutyunyan, O. N. Arzhanova [i dr.] // Zhurnal akusherstva i zhenskih bolezney. – 2013. – Tom 62, No. 6. – S. 25 – 36.
    • Kuznetsova I. V. Folievaya kislota i ee rol v zhenskoy reproduktsii / I. V. Kuznetsova, V. A. Kononova // Ginekologiya. – 2014. – No. 4. – S. 17 – 23.
    • Muhin N. A. Giper gomotsisteinemiya kak faktor riska razvitiya zabolevaniy serdechnoy-sosudistoy sistemyi / N. A. Muhin, S. V. Moiseev, V. V. Fomin // Klinicheskaya meditsina. – 2001. – No. 6. – S. 7 –14.
    • Makatsariya A. D. Gipergomotsisteinemiya i oslozhneniya beremennosti / A. D. Makatsariya, E. V. Beloborodova, S. M. Baymuradova [i dr.] // – M.: Triada-H, -2005.– 41 s.
    • Naumov A. V. Rol narusheniy protsessov metilirovaniya i obmena metionina v patogeneze zabolevaniy cheloveka / A. V. Naumov // Zhurnal GrGMU. – 2007. – T. 17, No. 1. – S. 4 – 7.
    • Reznikov A. G. Rol aktivnyih soedineniy folievoy kislotyi pri ispolzovanii kombinirovannyih oralnyih kontratseptivov / A. G. Reznikov // Reproduktivnaya endokrinologiya. – 2012. – T. 2, No. 4. – S. 48 – 51.
    • Toguzov R. T. Soderzhanie folatov i lipoevoy kislotyi v gepatoprotektore Progepar / R. T. Toguzov, E. S. Mamedov, E. N. Shachnev [i dr.] // Farmateka. – 2010. – T. 205, No. 11. – S. 77 – 82.
    • Trifanova E. A. Gomotsistein, polimorfizm gena MTHFR i oslozhneniya beremennosti / E. A. Trifanova, T. V. Gabidulina, G. A. Agarkovo [i dr.] // Akusherstvo i ginekologiya. – 2011. – No. 2. – S. 8 – 15.
    • Tapilskaya N.I. Ustranenie defitsita folatov-osnovnaya strategiya korrektsii gomotsisteinzavisimoy endotelialnoy disfunktsii / N. I. Tapilskaya, S.N. Aydukov // Ginekologiya. – 2013. – No. 3. – S. 70 – 74.
    • Angier R. B. Synthesis of a compound identical with the L. casei Factor isolated from liver/ R. B. Angier, J. H. Boothe, B. L. Hutchings [et al.] // Science. – 1945. – Vol. 102, № 2644. – P. 227– 228.
    • Brown A. S. Elevated prenatal homo-cysteine levels as a risk factor for schizophrenia / A. S. Brown, Т. Bottiglieri, C. A. Schaefer [et al.] // Arch. Gen. Psychiat. – 2007. – Vol. 64, № 1. – Р. 31 – 39.
    • Bailey S. W. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acidi intake / S. W. Bailey, J. E. Ayling // Proc. Nat. Acad. Sci. USA. – 2009. – Vol. 106, № 36. – Р. 15424 – 15429.
    • Bahmani F. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial / F. Bahmani, M. Karamali, H. Shakeri [et al.] // Clin. Endocrinol. (Oxf). –2014. – Vol. 81, № 4. – Р. 582 – 587.
    • Calle M. Increased homocysteine levels in polycystic ovary syndrome / M. Calle, T. Gallardo, M. D. Diestro [et al.] // Med. Clin. (Barc). – 2007. – Vol. 129, № 8. –Р. 292 – 294.
    • Caserta D. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping / D. Caserta, G. Adducchio, S. Picchia [et al.] // Gynecol. Endocrinol. – 2014. –Vol. 30, № 6. – Р. 397 – 402.
    • Dose-dependent effects of folic acid on blood concentrations of homocysteine:a meta-analysis of the randomized trials / Homocysteine Lowering Trialists’ Collaboration. // Am. J. Clin. Nutr. – 2005. – Vol. 82, № 4. – Р. 806 – 812.
    • Dubey P. Hyperhomocysteinemia: a risk factor in unexplained infertility / P. Dubey, N. Gupta, S. Dwivedi [et al.] // Inter. J. Reprod. Contracept. Obstet. Gynecol. – 2013. – Vol. 2, № 2. – Р. 165 – 171.
    • Daan N. M. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk ? / N. M. Daan, Y. V. Louwers, M. P. Koster [et al.] // Fertil Steril.– 2014. – Vol. 102, № 5. – Р. 1444 –1451.
    • Finkelstein J. D. Methionin metabolism in mammals / J. D. Finkelstein // J. Nutr. Biochem. – 1990. – Vol. 1. – P. 228 – 237.
    • Fowler B. Disorder of homocysteine metabolism / B. Fowler // J. Inter. Metab. – 1997. – Vol. 20, № 2. – P. 270 – 285.
    • Fawler B. The Follate cycle and Disease in humans / В. Fawler // Kidney Int. – 2001. – Vol. 59, № 78. – Р. 221 – 229.
    • Fowler B. Homocysteine: overwiew of biochenistry, molecular biology, and role in disease processes / B. Fowler // Semin. Vasc. Med. – 2005. – Vol. 5, № 2. – Р. 77 – 86.
    • Forges T. Impact of folate and homocysteine metabolism on human reproductive health / T. Forges, P. Monnier-Barbarino, J. Alberto [et al.] // Hum. Reprod. Update. – 2007. – Vol. 13, № 3. – Р. 225 – 238.
    • Forges T. Impact of folate and homocysteine metabolism on human reproductive health / T. Forges, P. Monnier-Barbarino, J. M. Alberto [et al.] // Hum. Reprod. – 2007. – Vol. 13, № 3. – Р. 225 – 238.
    • Forges T. Do folate have an implact of fertility / T. Forges, H. Pellanda, C. Diligent [et al.] // Gynecol. Obstet. Fertil. – 2008. – Vol. 36, № 9. – Р. 930 – 939.
    • Gaskins A. J. Dietary folate and reproductive success among women undergoing assisted reproduction / A. J. Gaskins, M. C. Afeiche, D. L. Wright [et al.] // Obstet. Gynecol. –2014. – Vol. 124, № 4. – Р. 801 – 809.
    • Harmon D. L. The common "thermolabile" variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia / D. L. Harmon, J. V. Woodside, J.W. Yarnell [et al.] // Q. J. Med. – 1996. – Vol. 89, № 8. – Р. 571 – 577.
    • Khaodhiar L. Obesity and comorbid conditions / L. Khaodhiar, K. C. Mc Cowen, G. L. Blackburn // Clin. Cornerstone. – 1999. – Vol. 2, № 1. – Р. 17 – 31.
    • Kao Y. H. Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis cardiovascular diseases genesis / Y. H. Kao, W. C. Chin, M. I. Hsu Samani [et al.] // Int. J. Fertil. Steril. – 2013. – Vol. 6, № 4. Р. 2008 – 2013.
    • Lindenbaum J. Oral contraceptive hormones, folate metabolism,and the cervical epithelium / J. Lindenbaum, N. Whitehead, F. Reyner // Am. J. Clin. Nutr. – 1975. – Vol. 28, № 4. – Р. 346 –353.
    • Loverro G. The plasma homocysteine levels are increased in polycystic ovary syndrome / G. Loverro, F. Lorusso, L. Mei [et al.] // Gynecol. Obstet. Invest. – 2002. – Vol. 53, № 3. – Р. 157 – 162.
    • Lavie L. Daily rhythms in plasma levels of homocysteine / L. Lavie // J. Circadian. Rhythms. – 2004. – Vol. 3. – P. 25 – 29.
    • Lim S. S. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis / S. S. Lim, R. J. Norman, M. J. Davies [et al.] // Obes. Rev. – 2013. – Vol. 14, № 2.– Р. 95 – 109.
    • Mohanty D. Effect of folate deficiency  on the reproductive organs of female rhesus monkeys: a cytomorphological and cytokinetic study / D. Mohanty, K. C. DAS // J. Nutr. – 1982. – Vol. 112, № 8. – Р. 1565 – 1576.
    • MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study // Lancet. – 1991. – Vol. 338, № 8760. – P. 131– 137.
    • Medina M. Roles of homocysteine in cell metabolism: old and new functions / M. Medina // Eur. J. Biochem. – 2001. – Vol. 286.– P. 3871 – 3882.
    • Moat S. J. Folate, homocysteine, endothelial function and cardiovascular disease / S. J. Moat, D. Lang, I. F. Mc Dowell [et al.] // J. Nutr. Biochem. – 2004. – Vol. 15, № 2. – Р 64 – 79.
    • Maleedhu Р. Status of Homocysteine in Polycystic Ovary Syndrome (PCOS) / P. Maleedhu, P. K. Kodumuri, D. V. Devi // J. Clin. Diagn. Res. – 2014. – Vol. 8, № 2. – Р. 32 – 33.
    • Nafiye Y. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization out come / Y. Nafiye, K. Sevtap, D. Muammer [et al.] // Fertil. Steril. – 2010. – Vol. 93, № 6. – Р. 1864 – 1869.
    • Orio F. Early impairment of endothelial structure and function in young normal- weight women with polycystic ovary syndrome / F. Orio, S. Palomba, T. Cascella // J. Clin. Endоcrinol. Metabol. – 2004. – Vol. 89, № 9. – Р. 4588 – 4593.
    • Pietrzik K. Folic acid and L-5-methyltetrahydrofo late: comparison of clinical pharmacokinetics and pharmacodynamics / K. Pietrzik, L. Bailey, B. Shane // Clin. Pharmacokinet. – 2010. – Vol. 49, № 8. – Р. 535 – 548.
    • Qiao J. Extra-and intra- ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence / J. Qiao, H. L. Fend // Hum. Reprod. Updata. – 2011. – Vol. 17, № 1. – Р. 17 – 33.
    • Selhub J. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population / J. Selhub, P. F. Jacques, P. W. Wilson [et al.] // JAMA. – 1993. – Vol. 270, № 2. – P. 2693 – 2698.
    • Sills E. S. Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility / E. S. Sills, M. G. Genton, M. Perloe [et al.] // Obstet. Gynaecol. Res. – 2001. – Vol. 27, № 3. – Р. 163 –168.
    • Salehpour S. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome / S. Salehpour, О. Manzor-Al-Ajdad, E. N. Samani [et al.] // Int. J. Fertil. Steril. – 2011. – Vol. 4, № 4. – Р. 168 –171.
    • Salehpour S. Evaluation of homocysteine levels in patients with polycystic ovary syndrome / S. Salehpour, O. Manzor-al-ajdad, E. Neisani Samani [et al.] // Int. J. Fertil. Steril. – 2011. – Vol. 4, № 4. – Р. 168 – 171.
    • Schachter M. Insulin resistence in patient with polycystic ovary  syndrome is associated with elevated plasma homocysteine / M. Schachter, A. Raziel, S. Friedler [et al.] // Hum. Reprod. – 2003. – Vol. 18, № 4. – Р. 721 – 727.
    • Sohrabvand F. Serum homocystein  levels in PCOS patients versus healthy women / F. Sohrabvand, M. Lankarani,  B. Golestan [et al.] // J. Reprod. Infertility. – 2009. – 9, № 37. – Р. 334 – 341.
    • Simpson J. L. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess / J. L. Simpson, L. B. Bailey, K. Pietrzik [et al.] // J. Matern. Fetal. Neonatal. Med. – 2010. – Vol. 23, № 12. – Р. 1323 – 1343.
    • Tsanadis G. Polycystic ovarian syndrome and thrombophilia / G. Tsanadis, G. Vartholomatos, I. Korkontzelos [et al.] // Hum. Reprod. – 2002. – Vol. 17, № 2. – Р. 314 – 319.
    • The Rotterdam ESHRE/ ASRM- sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteriaand long-term health risks related to polycystic ovary syndrome (PCOS) // Hum. Reprod. – 2004. – Vol. 19, № 1. – P. 41 – 47.
    • Tamura T. Folate and human reproduction / T. Tamura, M. F. Pacciano // Am.J. Clin. Nutr. – 2006. – Vol. 83, № 5. – Р. 933 – 1016.
    • Vanaerts L. A. Prevention of neural tube defects by and toxicity of L?homocysteine in cultured postimplantation rat embryos / L. A. Vanaerts, H. J. Blom, R. A. Deabreu [et al.] // Teratology. – 1994. – Vol. 50, № 5. – P. 348 – 360.
    • van der Put N. M. Folate, homocysteine and neural tube defects: an overview /, H. W. van Straaten [et al.] // Exp. Biol. Med. – 2001 – Vol. 226, № 4. – P. 243 – 270.
    • Van Bejnum, I. M. Total homocysteine and its predictors in Dutch children / I. M. van Bejnum // Am. J. Clin. Nutr. – 2005. – Vol. 81. – P. 1110 – 1116.
    • Willmott M. The effect of folicacid on superovulation in the immature rat / M. Willmott, D. B. Bartosik , E. B. Romanoff // J. Endocrinol. – 1986. – Vol. 43, № 3. – 439 – 445.
    • Wani N. A. Folate status in various pathophysiological conditions / N. A. Wani, A. Hamid, J. Kaur // IUBMB Life. – 2008. – Vol. 60, № 12 – P. 834 – 842.
    • Yilmaz M. Levels of lipoprotein and homocystein in non-obese and obese patients with polycystic ovary syndrome / M. Yilmaz, A. Biri, N. Bukan [et al.] // Gynecol. Endocrinol. – 2005. – Vol.20, № 5. – Р. 258 – 263. 
    Publication of the article «World of Medicine and Biology» №1(55), 2016 year, 009-017 pages, index UDK 577.164.17:618.11-006.2:618.179